Castle Biosciences Chief Commercial Officer Tobin W Juvenal Reports Sale of $108,767.04 in Common Shares
Bitget2026/10/28 20:09- Castle Biosciences Chief Commercial Officer Tobin W. Juvenal sold 3,288 shares of common stock on October 26, 2026.
- The reported sale price was $33.08 per share, leaving Juvenal with 45,431 directly owned shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December
Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.
Crypto prices
More
